- $1.88bn
- $1.53bn
- $207.54m
- 36
- 12
- 91
- 44
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 4.46 | ||
Price to Tang. Book | 4.51 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 9.06 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -33.14% | ||
Return on Equity | -38.58% | ||
Operating Margin | -100.85% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 108.09 | 137.93 | 180.96 | 216.67 | 207.54 | 252.54 | 299.5 | 19.39% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.
Directors
- Michael Lynton NEC (61)
- Ramy Farid PRE (56)
- Joel Lebowitz CFO (57)
- Kenneth Lorton EVP (37)
- Robert Abel EVP (39)
- Karen Akinsanya EVP (53)
- Yvonne Tran EVP (50)
- Richard Friesner DRC (68)
- Jeffrey Chodakewitz IND (65)
- Gary Ginsberg IND (58)
- Rosana Kapeller-Libermann IND (57)
- Gary Sender IND (59)
- Nancy Thornberry IND (64)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 22nd, 1995
- Public Since
- February 6th, 2020
- No. of Shareholders
- 87
- No. of Employees
- 891
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 73,038,393

- Address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, 10036
- Web
- https://www.schrodinger.com
- Phone
- +1 5032991150
- Auditors
- KPMG LLP
Upcoming Events for SDGR
Schrodinger Inc Annual Shareholders Meeting
Q2 2025 Schrodinger Inc Earnings Release
FAQ
As of Today at 23:06 UTC, shares in Schrodinger are trading at $25.75. This share price information is delayed by 15 minutes.
Shares in Schrodinger last closed at $25.75 and the price had moved by +2.84% over the past 365 days. In terms of relative price strength the Schrodinger share price has underperformed the S&P500 Index by -3.31% over the past year.
The overall consensus recommendation for Schrodinger is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSchrodinger does not currently pay a dividend.
Schrodinger does not currently pay a dividend.
Schrodinger does not currently pay a dividend.
To buy shares in Schrodinger you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $25.75, shares in Schrodinger had a market capitalisation of $1.88bn.
Here are the trading details for Schrodinger:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: SDGR
Based on an overall assessment of its quality, value and momentum Schrodinger is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Schrodinger is $31.33. That is 21.67% above the last closing price of $25.75.
Analysts covering Schrodinger currently have a consensus Earnings Per Share (EPS) forecast of -$2.55 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Schrodinger. Over the past six months, its share price has outperformed the S&P500 Index by +60.31%.
As of the last closing price of $25.75, shares in Schrodinger were trading +23.59% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Schrodinger PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $25.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Schrodinger's management team is headed by:
- Michael Lynton - NEC
- Ramy Farid - PRE
- Joel Lebowitz - CFO
- Kenneth Lorton - EVP
- Robert Abel - EVP
- Karen Akinsanya - EVP
- Yvonne Tran - EVP
- Richard Friesner - DRC
- Jeffrey Chodakewitz - IND
- Gary Ginsberg - IND
- Rosana Kapeller-Libermann - IND
- Gary Sender - IND
- Nancy Thornberry - IND